Start Free Trial
Pricing
Log In
Log In
Upgrade browser for full Crunchbase experience. You're accessing Crunchbase in a browser that is no longer supported.
Learn More
Inibio Logo
Inibio Growth Score
68
CB Rank
96296
Heat Score
78
Inibio is a biomedical firm that specializes in medical aesthetics and develops botox from organic components.
Founded
obfuscation
PrivateSeries B Gyeongju, Kyongsang-bukto, South Korea51-100 www.inibio.com
Biopharma
Pharmaceutical
Overview

Inibio
Total Funding
obfuscation
Growth Score
68
Heat Score
78

Total Funding
obfuscation
obfuscation
Series B raised
obfuscation
Growth Score68
-3 pts
in past quarter
Heat Score 78
-10 pts
in past quarter

Company Performance Metrics

Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Learn More >
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience

About Inibio

CB Rank
96296
Inibio is a biomedical firm that specializes in medical aesthetics and develops botox from organic components.
Founded
obfuscation
PrivateSeries B Gyeongju, Kyongsang-bukto, South Korea51-100 www.inibio.com
Biopharma
Pharmaceutical

Funding Rounds

Series B
OBF
in
obfuscation
Venture - Series Unknown
OBF
in
obfuscation
Seed
OBF
in
obfuscation

Details

Legal Name Inibio Co., Ltd.
Also Known As 이니바이오
Operating Status Active
Company Type For Profit
Phone Number +82 032 683 8080
Contact Email inibio@inibio.com
Predictions & Insights

Growth Prediction

See this Growth Prediction

Products & Services

Organic Botox
A botulinum toxin product derived from organic components used in medical aesthetics to reduce wrinkles and fine lines.

Research & Development

Inibio is

obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
...

Unlock More with Crunchbase Pro
  • Full access to financial & funding data on unlimited profiles
  • Export up to 2k results/month for analysis
  • Track market signals on competitors, products, and R&D
  • Preview private company insights and predictions
Financials

Company Funding

Total Funding Amount 
obfuscation
Number of Funding Rounds 3
Unlock company funding data, including rounds, dates, amounts, and investors.
Announced Date  
Transaction Name  
Number of Investors  
Money Raised  
Lead Investors  
Funding Type  
obfuscation
Series B - Inibio Logo
Series B - Inibio
5
obfuscation
— Series B
obfuscation
Series B - Inibio Logo
Series B - Inibio
5
obfuscation
— Series B
obfuscation
Series B - Inibio Logo
Series B - Inibio
5
obfuscation
— Series B
obfuscation
Series B - Inibio Logo
Series B - Inibio
5
obfuscation
— Series B
obfuscation
Series B - Inibio Logo
Series B - Inibio
5
obfuscation
— Series B

Funding Rounds

Total Funding Amount 
obfuscation
Number of Funding Rounds 3
Unlock company funding data, including rounds, dates, amounts, and investors.
Announced Date  
Transaction Name  
Number of Investors  
Money Raised  
Lead Investors  
Funding Type  
obfuscation
Series B - Inibio Logo
Series B - Inibio
5
obfuscation
— Series B
obfuscation
Series B - Inibio Logo
Series B - Inibio
5
obfuscation
— Series B
obfuscation
Series B - Inibio Logo
Series B - Inibio
5
obfuscation
— Series B
obfuscation
Series B - Inibio Logo
Series B - Inibio
5
obfuscation
— Series B
obfuscation
Series B - Inibio Logo
Series B - Inibio
5
obfuscation
— Series B

Investors

Unlock company funding data, including rounds, dates, amounts, and investors.
Investor Name  
Lead Investor  
Funding Round  
Partners  
NH Hedge Asset Management Logo
NH Hedge Asset Management
—
Series B - Inibio Logo
Series B - Inibio
—
NH Hedge Asset Management Logo
NH Hedge Asset Management
—
Series B - Inibio Logo
Series B - Inibio
—
NH Hedge Asset Management Logo
NH Hedge Asset Management
—
Series B - Inibio Logo
Series B - Inibio
—
NH Hedge Asset Management Logo
NH Hedge Asset Management
—
Series B - Inibio Logo
Series B - Inibio
—
NH Hedge Asset Management Logo
NH Hedge Asset Management
—
Series B - Inibio Logo
Series B - Inibio
—
Market Intelligence
People
View Profiles & Contacts
Headcount 51-100
News

News and Press

News•Jul 22, 2022
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
Access a complete feed of recent news and press, from product launches to leadership changes.
Technology
View Tech Report

Monthly Web Visits

342
-36.19%
 in past month

Interest Signals

TopicSurge Score
Cloud-Native Security Logo
Cloud-Native Security
75
Quest Logo
Quest
75
Cloud Capacity Logo
Cloud Capacity
75

Active Website Tech Count

3Inibio is actively using 3 technologies for its website, according to BuiltWith. These include Euro, SPF, and  South Korean Server Location.
Sub-Organizations
Frequently Asked Questions

Where is Inibio's headquarters? Inibio is located in Gyeongju, Kyongsang-bukto, South Korea.Who invested in Inibio? Inibio has 5 investors including NH Hedge Asset Management and  RKPSG.When was the last funding round for Inibio? Inibio closed its last funding round on
obfuscation
from a Series B round.Who are Inibio's competitors? Alternatives and possible competitors to Inibio may include Medytox, BOTOX Cosmetic, and  Dysport.How much funding has Inibio raised to date? Inibio has raised
obfuscation
.
Who We Are
What We Do
Helpful Links
AI Content may contain mistakes and is not legal, financial or investment advice. Learn more.
Terms of Service | Privacy Policy | Sitemap | © 2026 Crunchbase Inc. All Rights Reserved.
(ccb7a32 1)
|